Page last updated: 2024-10-29

ketoprofen and Pseudotumor Cerebri

ketoprofen has been researched along with Pseudotumor Cerebri in 1 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larizza, D1
Colombo, A1
Lorini, R1
Severi, F1

Other Studies

1 other study available for ketoprofen and Pseudotumor Cerebri

ArticleYear
Ketoprofen causing pseudotumor cerebri in Bartter's syndrome.
    The New England journal of medicine, 1979, Apr-05, Volume: 300, Issue:14

    Topics: Bartter Syndrome; Child; Female; Humans; Hyperaldosteronism; Ketoprofen; Phenylpropionates; Pseudotu

1979